GGAAF — NeuroMind AI Cashflow Statement
0.000.00%
FinancialsSpeculativeMicro Cap
Annual cashflow statement for NeuroMind AI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.109 | 0.338 | 0.421 |
| Non-Cash Items | -0.001 | -3.63 | -1.66 |
| Unusual Items | |||
| Changes in Working Capital | 0.077 | 2.4 | 0.168 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.033 | -0.896 | -1.07 |
| Other Investing Cash Flow Items | -257 | -1.41 | 265 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -257 | -1.41 | 265 |
| Financing Cash Flow Items | -2.95 | 0 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 259 | 2.3 | -264 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2.33 | 0 | 0 |